Jerome D. Goldberg

Array ( [id] => 3939910 [patent_doc_number] => 05872142 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Pharmaceutical compositions for inhibiting the growth of cancers' [patent_app_type] => 1 [patent_app_number] => 8/792741 [patent_app_country] => US [patent_app_date] => 1997-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3002 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/872/05872142.pdf [firstpage_image] =>[orig_patent_app_number] => 792741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4133416 [patent_doc_number] => 06121245 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Method of treating cancer using alkylglycerols in conjunction with chemotherapy' [patent_app_type] => 1 [patent_app_number] => 8/791757 [patent_app_country] => US [patent_app_date] => 1997-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6216 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/121/06121245.pdf [firstpage_image] =>[orig_patent_app_number] => 791757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3961036 [patent_doc_number] => 05900429 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-04 [patent_title] => 'Method for inhibiting the growth of cancers' [patent_app_type] => 1 [patent_app_number] => 8/788482 [patent_app_country] => US [patent_app_date] => 1997-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3321 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/900/05900429.pdf [firstpage_image] =>[orig_patent_app_number] => 788482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3742472 [patent_doc_number] => 05786376 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-28 [patent_title] => 'Methods of treating opportunistic infections with azaspiranes' [patent_app_type] => 1 [patent_app_number] => 8/507487 [patent_app_country] => US [patent_app_date] => 1997-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 1 [patent_no_of_words] => 2617 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 209 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/786/05786376.pdf [firstpage_image] =>[orig_patent_app_number] => 507487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3944116 [patent_doc_number] => 05990125 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'NK-1 receptor antagonists for the treatment of cancer' [patent_app_type] => 1 [patent_app_number] => 8/786128 [patent_app_country] => US [patent_app_date] => 1997-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18208 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/990/05990125.pdf [firstpage_image] =>[orig_patent_app_number] => 786128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3961050 [patent_doc_number] => 05900430 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-04 [patent_title] => 'Cytokine inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/779418 [patent_app_country] => US [patent_app_date] => 1997-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3534 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 256 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/900/05900430.pdf [firstpage_image] =>[orig_patent_app_number] => 779418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3762836 [patent_doc_number] => 05852059 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Use of droloxifene for the treatment of protastic disease, endometriosis and obesity' [patent_app_type] => 1 [patent_app_number] => 8/750860 [patent_app_country] => US [patent_app_date] => 1997-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1324 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/852/05852059.pdf [firstpage_image] =>[orig_patent_app_number] => 750860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4347025 [patent_doc_number] => 06284799 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Cancer treatment' [patent_app_type] => 1 [patent_app_number] => 8/773987 [patent_app_country] => US [patent_app_date] => 1996-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 3626 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 207 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284799.pdf [firstpage_image] =>[orig_patent_app_number] => 773987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3950538 [patent_doc_number] => 05955498 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Agent for prophylaxis and therapy of diseases' [patent_app_type] => 1 [patent_app_number] => 8/765298 [patent_app_country] => US [patent_app_date] => 1996-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2125 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955498.pdf [firstpage_image] =>[orig_patent_app_number] => 765298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4008965 [patent_doc_number] => 05889017 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Method for treating cancer with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof' [patent_app_type] => 1 [patent_app_number] => 8/767861 [patent_app_country] => US [patent_app_date] => 1996-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 6160 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/889/05889017.pdf [firstpage_image] =>[orig_patent_app_number] => 767861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4058288 [patent_doc_number] => 05863914 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-26 [patent_title] => 'N,N-di(aryl) cyclic urea derivatives as anti-coagulants' [patent_app_type] => 1 [patent_app_number] => 8/764028 [patent_app_country] => US [patent_app_date] => 1996-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15111 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 476 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/863/05863914.pdf [firstpage_image] =>[orig_patent_app_number] => 764028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4003099 [patent_doc_number] => 05859005 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'N,N-di(aryl) cyclic urea derivatives as anti-coagulants' [patent_app_type] => 1 [patent_app_number] => 8/764500 [patent_app_country] => US [patent_app_date] => 1996-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15121 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 460 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/859/05859005.pdf [firstpage_image] =>[orig_patent_app_number] => 764500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3850986 [patent_doc_number] => 05767110 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Combination chemotherapy' [patent_app_type] => 1 [patent_app_number] => 8/763601 [patent_app_country] => US [patent_app_date] => 1996-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 1768 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767110.pdf [firstpage_image] =>[orig_patent_app_number] => 763601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4119292 [patent_doc_number] => 06071949 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents' [patent_app_type] => 1 [patent_app_number] => 8/704569 [patent_app_country] => US [patent_app_date] => 1996-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 3831 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/071/06071949.pdf [firstpage_image] =>[orig_patent_app_number] => 704569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3895730 [patent_doc_number] => 05750515 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-12 [patent_title] => 'Cancer metastasis inhibitor' [patent_app_type] => 1 [patent_app_number] => 8/737799 [patent_app_country] => US [patent_app_date] => 1996-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3304 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/750/05750515.pdf [firstpage_image] =>[orig_patent_app_number] => 737799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4075183 [patent_doc_number] => 05965595 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => '2-Imidazolinylamino heterocyclic compounds useful as alpha-2 adrenoceptor agonists' [patent_app_type] => 1 [patent_app_number] => 8/756085 [patent_app_country] => US [patent_app_date] => 1996-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16641 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965595.pdf [firstpage_image] =>[orig_patent_app_number] => 756085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3732891 [patent_doc_number] => 05665761 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-09 [patent_title] => 'Methods for administration of taxol' [patent_app_type] => 1 [patent_app_number] => 8/755740 [patent_app_country] => US [patent_app_date] => 1996-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7684 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/665/05665761.pdf [firstpage_image] =>[orig_patent_app_number] => 755740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4314582 [patent_doc_number] => 06248368 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Use of magnesium based products for the treatment or prophylaxis of autoimmune diseases' [patent_app_type] => 1 [patent_app_number] => 8/737743 [patent_app_country] => US [patent_app_date] => 1996-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5493 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248368.pdf [firstpage_image] =>[orig_patent_app_number] => 737743 [rel_patent_id] =>[rel_patent_doc_number] =>)